Skyler Greene
Skyler Greene
Send Message
Skyler Greene
Stop FollowingSkyler Greene
View as an RSS Feed
View Skyler Greene's Articles BY TICKER:
AAPL,
AEO,
AET,
AIG,
AMZN,
APOG,
BAC,
BDE,
BKE,
BKW,
BRK.B,
C,
CAT,
CHK,
CMG,
CMI,
CSCO,
DE,
DELL,
DFS,
DPS,
DVY,
ECA,
F,
FB,
FDX,
GA,
GLD,
GMCR,
GOOG,
GRPN,
HPQ,
INTC,
JNJ,
JPM,
KKD,
KO,
KSS,
LNKD,
LYB,
M,
MCD,
MSFT,
NLY,
PBI,
PEP,
PFE,
PG,
SDY,
SLV,
SPY,
STX,
TLT,
VIAB,
VIG,
VLO,
WCG,
WDC,
WEN,
XLB,
YHOO,
ZNGA
- Hewlett-Packard: Value Trap Or Fallen Angel?
-
Why Dell Is A Must-Buy: The Comprehensive Bull Thesis
- Pepsi Vs Coke: Confessions Of A Pepsi-Investing Coke-A-Holic
- Why Investors Should Never Focus Exclusively On Share Price
- Marissa Mayer's Ambitious Acquisition Plans: Not Your Grandma's Yahoo
- Cisco: You Don't Need An Analyst To Recognize Value
- Modern Investing Adages, Part 1: Don't Buy What You Don't Know
- Johnson & Johnson's Deceptive Valuation
- Index Investing: One Size Doesn't Fit All
- Green Mountain Coffee Roasters: Momo Trap To Deep Value
- Annaly Capital Management: Point-Counterpoint With Regarded Solutions
- Why We Should All Stop Talking About 'Dividend Stock' Valuations
- My Favorite Retailer Is On Sale Now
- Tick-Tock: The Intel Party Doesn't Stop
- Microsoft, The Cheap And Innovative iPad Killer
- Silver Manipulation: CFT Drops Probe
- The Everything-You-Need Portfolio: A Commodities Play
- Utilities: The Power Surge Is Over
-
Buy One Berkshire Hathaway, Get One Warren Buffett Free!
- Takeaway From Knight Capital: Invest In The Market, Not The Exchanges
-
An Underappreciated And Important Aspect Of The Cisco NDS Acquisition
- How Far Can Facebook Fall? Another 50%
- Procter & Gamble Earnings Recap: Will Strong Results Continue?
-
Blanket Fort Investing
on Thu, Aug 2, 2012 • 6 Comments
- Why Corporate Earnings Absolutely Won't Drop 50%: A Historical Perspective
- Ford: Tough Track But Very Cheap
- LinkedIn Earnings Preview: Love The Company, Hate The Stock
- Variable-Rate Treasuries: An Investor's Best Friend
-
Believe In The Cult Of Equity
- The Problem With Facebook: Mark Zuckerberg Is Unfixable
-
The Insane Market Hypothesis
- Pfizer's New Pharma Model
